期刊文献+

TAFI基因编码区的单核苷酸多态性与脑梗死的相关性探讨 被引量:3

The Association between Single Nucleotide Polymorphisms in the Coding Region of TAFI Gene and Cerebral Infarction
下载PDF
导出
摘要 目的 凝血酶激活的纤溶抑制物 (Thrombinactivatablefibrinolysisinhibitor ,TAFI)具有抑制纤维蛋白溶解的功能 ,它在止血中起重要的作用。TAFI的血浆浓度是受TAFI基因变异调节的 ,因此TAFI基因可能是脑梗死的候选基因之一。探讨TAFI基因单核苷酸的多态性与脑梗死的关系。方法 收集了 189例尸体检查的样本 ,其中包括 95例脑梗死和 94例的对照组。TAFI基因G5 0 5A和C10 4 0T的基因型是用PCR -RFLP(Restrictionfragmentlengthpolymorphism)法来分析。 结果 G5 0 5AandC10 4 0T的基因型频率分布是A5 0 5A 12 (6 % ) ,G5 0 5A 75 (4 0 % ) ,G5 0 5G 10 2 (5 4 % ) ;C10 4 0C 139(74 % ) ,C10 4 0T 4 5 (2 3% ) ,T10 4 0T 5 (3% )。在脑梗死组和对照组之间 ,这些基因型的分布没有显著性差别 (P >0 .0 5 )。结论 TAFI基因单核苷酸的多态性 (G5 0 5A和C10 4 0T)与脑梗死没有显著性相关。 Objective Thrombin activatable fibrinolysis inhibitor (TAFI) plays an important role in hemostasis, functioning as a potent fibrinolysis inhibitor. TAFI gene variations contribute to plasma TAFI levels, so it is maybe a candidate gene of cerebral infarction. Our aim is to find the association between the polymorphisms of TAFI gene and cerebral infarction.Methods Clinicopathological data from 189 autopsies were analyzed, and 95 cerebral infarction patients and 94 controls were included. PCR-RFLP (Restriction fragment length polymorphism) method was used to genotype the polymorphism of G505A and C1040T of TAFI gene.Results The genotyping frequencies of G505A and C1040T were A505A 12(6%), G505A 75(40%), G505G 102(54%); C1040C 139(74%), C1040T 45(23%), T1040T 5(3%), respectively. Chi-square analyses showed that the difference of these genotyping frequencies between the cases and controls was not significant(P>0.05).Conclusions Our results indicated that the polymorphisms(G505A and C1040T)of TAFI gene were not associated with cerebral infarction.
出处 《神经疾病与精神卫生》 2003年第6期419-421,共3页 Journal of Neuroscience and Mental Health
关键词 脑梗死 TAFI基因 单核苷酸多态性 相关性 病理学 TAFI gene SNP(single nucleotide polymorphism) Cerebral infarction Pathology
  • 相关文献

参考文献16

  • 1[1]Bajzar L, Nesheim ME, Tracy PB ,et al. The profibrinolytic effect of activated protein C in clots formed from plasma is TAFI- dependent[J]. Blood, 1996,88 (6): 2 093 - 2 100.
  • 2[2]Sakharov DV, Plow EF, Rijken DC, et al. On the mechanism of the antifibrinolytic activity of plasma carboxypeptidase B[J]. The Journal of Biological Chemistry, 1997, 272 (22): 14 477-14 482.
  • 3[3]Wang W, Boffa MB, Bajzar L ,et al. A study of the mecha nism of inhibition of fibrinolysis by activated thrombin- acti vatable fibrinolysis inhibitor [J]. The Journal of Biological Chemistry,1998,273(42) :27 176-21 781.
  • 4[4]Boffa MB, Reid TS, Joo E ,et al. Characterization of the gene encoding human TAFI (Thrombin- activable fibrinolysis in hibitor; plasma procarboxypeptidase B) [J]. Biochemistry, 1999,38(20) :6 547-6 558.
  • 5[5]Zhao L, Morser J, Bajzar L, et al. Identification and charac terization of two thrombin- activatable fibrinolysis inhibitor isoforms[J]. Thrombosis Haemostasis, 1998, 80 (6) : 949 - 955.
  • 6[6]Minnema MC, Friederich PW, Levi M, et al. Enhancement of rabbit jugular vein thrombolysis by neutralization of factor Ⅺ: in vivo evidence for a role of factor Ⅺ as an anti-fibrinolytic factor[J]. The Journal of Clinical Investigation, 1998, 101 (1) :10-14.
  • 7[7]Nagashima M, Werner M, Wang M, et al. An inhibitor of ac tivated thrombin-activatable fibrinolysis inhibitor potentiates tissue-type plasminogen activator-induced thrombolysis in a rabbit jugular vein thrombolysis model[J]. Thrombosis Re seach, 2000,98(4) :333-342.
  • 8[8]Van Tilburg NH, Rosendaal FR, Bertina RM ,et al. Throm bin activable fibrinolysis inhibitor and the risk for deep vein thrombosis[J]. Blood,2000,95(9) :2 855-2 859.
  • 9[9]Juhan-Vague I, Renucci JF, Grimaux M, et al. TAFI anti gen levels and cardiovascular risk factors. Arteriosclerosis[J]. Thrombosis and Vascular Biology,2000,20(9):2 156-2 161.
  • 10[10]Juhan-Vague I, Morange PE, Aubert H, et al. Plasma thrombin-activatable fibrinolysis inhibitor antigen con centration and genotype in relation to myocardial infarc tion in the north and south of Europe[J]. Arteriosclero sis, Thrombosis and Vascular Biology, 2002,22 (5): 867 - 873.

同被引文献26

  • 1各类脑血管疾病诊断要点[J].中华神经科杂志,1996,29(6):379-380. 被引量:33009
  • 2Franco. RF,Fagundes MG,Meijers JC,et aL Identification of polymorphisms in the 5"-untranslate dregion of the TAFI gene relationship with plasma TAFI levels and risk of venous thrombosis[J].Haematologica,2001,86(5):510-517.
  • 3Michael BB, Marlys LK. Recent advances in measurement of thrombin-activatable fibrinolysis inhibitor(TAFI)and in understanding its molecular genetics, gene regulation,and biological roles (review)[J]. Clinical Biochemistry, 2007, 40 (5):431-442.
  • 4Bjorkman JA, Abrahamsson TI, Nerme VK, et al. Inhibition of carboxypeptidase U(TAFIa) activityimproves rt-PA induced thrombolysis in a dog model of coronary artery thrombosis[J]. Thromb Res,2005,116(6):519-524.
  • 5Juhan-Vague I, Morange PE, Aubert H, et al.Plasma thrombinactivatable fibfinolysis inhibitor antigen concentration and genotype in relation to myocardial infarction in the north and south of Europe[J]. Arterioscler Thromb Vasc Biol, 2002, 22(5 ) : 867-873.
  • 6Morange PE, Tregouet DA,FRERE C,et al. TAFI gene hap- lotypes, TAFI plasma levels and future risk of coronary heart disease: the prime study[J]. J Thromb Haemost,2005,3(7): 1503-1510.
  • 7Brouwers GJ, Vos HL, Leebeek FW, et al. A novel, possibly functional, single nucleotide polymorphism in the coding re- gion of the thrombin-activatable fibrinolysis inhibitor (TAFI) gene is also associated with TAFI levels[J]. Blood,2001,98 (6):1992-1993.
  • 8Bajzar L,Nesheim ME,Tracy PB.The profibrinolytic effect of activated protein C in clots formed from plasma is TAFI-dependent[J].Blood,1996,88(6):2093-2100.
  • 9Sakharov DV,Plow EF,Rijken DC.On the mechanism of the antifibrinolytic activity of plasma carboxypeptidase B [J].J Biol Chem,1997,272(22):14477-14482.
  • 10Wang W,Boffa MB,Bajzar L,et al.A study of the mechanism of inhibition of fibrinolysis by activated thrombin -activable fibrinolysis inhibitor[J].J Biol Chem, 1998,273(42):27176-27181.

引证文献3

二级引证文献1

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部